TIS 0.00% 0.0¢ tissue therapies limited

Oral explanation to be held on Wednesday 25 March 2015 at 11.00, page-54

  1. 2,617 Posts.
    lightbulb Created with Sketch. 4
    Puzzled: "Of course, there is always a risk with any bio product that it won't go all the way"

    But TIS has gone 'all the way' - VitroGro does work. In reaching this conclusion we followed the path laid out by the various regulatory bodies in Europe. If/when the rules change there should be a period of transition for businesses such as TIS who are caught in the midst of this change. So long as the product does what it sets out to do and there is no known risk to the public, then it should be given the appropriate mark of approval.

    I find it hard to believe that in the event that we are not granted CE mark then TIS is worthless - the science exists, it is patented and it works - surely that is worth something - probably a lot.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.